Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens
- 31 May 2001
- Vol. 57 (5) , 999-1005
- https://doi.org/10.1016/s0090-4295(00)01052-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- SAW PALMETTO FOR THE TREATMENT OF MEN WITH LOWER URINARY TRACT SYMPTOMSJournal of Urology, 2000
- Saw Palmetto Extracts for Treatment of Benign Prostatic HyperplasiaJAMA, 1998
- Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaThe Prostate, 1998
- Prostate Tissue Composition and Response to Finasteride in Men With Symptomatic Benign Prostatic HyperplasiaJournal of Urology, 1997
- Phytotherapy in treatment of benign prostatic hyperplasia: a critical reviewUrology, 1996
- Effects of the Sabal serrulata extract IDS 89 and its subfractions on 5α-reductase activity in human benign prostatic hyperplasiaThe Prostate, 1996
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male VolunteersEuropean Urology, 1994
- Comparison of finasteride (proscar®), a 5α reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α reductase inhibitionThe Prostate, 1993
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984
- Estrogens in Fetal and Maternal Plasma of the Rhesus MonkeyEndocrinology, 1975